Literature DB >> 23202376

Hybrid MV-kV 3D respiratory motion tracking during radiation therapy with low imaging dose.

Huagang Yan1, Haiyun Li, Zhixiang Liu, Ravinder Nath, Wu Liu.   

Abstract

A novel real-time adaptive MV-kV imaging framework for image-guided radiation therapy is developed to reduce the thoracic and abdominal tumor targeting uncertainty caused by respiration-induced intrafraction motion with ultra-low patient imaging dose. In our method, continuous stereoscopic MV-kV imaging is used at the beginning of a radiation therapy delivery for several seconds to measure the implanted marker positions. After this stereoscopic imaging period, the kV imager is switched off except for the times when no fiducial marker is detected in the cine-MV images. The 3D time-varying marker positions are estimated by combining the MV 2D projection data and the motion correlations between directional components of marker motion established from the stereoscopic imaging period and updated afterwards; in particular, the most likely position is assumed to be the position on the projection line that has the shortest distance to the first principal component line segment constructed from previous trajectory points. An adaptive windowed auto-regressive prediction is utilized to predict the marker position a short time later (310 ms and 460 ms in this study) to allow for tracking system latency. To demonstrate the feasibility and evaluate the accuracy of the proposed method, computer simulations were performed for both arc and fixed-gantry deliveries using 66 h of retrospective tumor motion data from 42 patients treated for thoracic or abdominal cancers. The simulations reveal that using our hybrid approach, a smaller than 1.2 mm or 1.5 mm root-mean-square tracking error can be achieved at a system latency of 310 ms or 460 ms, respectively. Because the kV imaging is only used for a short period of time in our method, extra patient imaging dose can be reduced by an order of magnitude compared to continuous MV-kV imaging, while the clinical tumor targeting accuracy for thoracic or abdominal cancers is maintained. Furthermore, no additional hardware is required with the proposed method.

Entities:  

Mesh:

Year:  2012        PMID: 23202376     DOI: 10.1088/0031-9155/57/24/8455

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  6 in total

1.  Optimizing fiducial visibility on periodically acquired megavoltage and kilovoltage image pairs during prostate volumetric modulated arc therapy.

Authors:  Pengpeng Zhang; Laura Happersett; Bosky Ravindranath; Michael Zelefsky; Gig Mageras; Margie Hunt
Journal:  Med Phys       Date:  2016-05       Impact factor: 4.071

2.  Intrafractional 3D localization using kilovoltage digital tomosynthesis for sliding-window intensity modulated radiation therapy.

Authors:  Pengpeng Zhang; Margie Hunt; Hai Pham; Grace Tang; Gig Mageras
Journal:  Phys Med Biol       Date:  2015-08-25       Impact factor: 3.609

3.  Technical Note: 3D localization of lung tumors on cone beam CT projections via a convolutional recurrent neural network.

Authors:  Chuang Wang; Margie Hunt; Lei Zhang; Andreas Rimner; Ellen Yorke; Michael Lovelock; Xiang Li; Tianfang Li; Gig Mageras; Pengpeng Zhang
Journal:  Med Phys       Date:  2020-01-28       Impact factor: 4.071

4.  Design and validation of a MV/kV imaging-based markerless tracking system for assessing real-time lung tumor motion.

Authors:  Pengpeng Zhang; Margie Hunt; Arina B Telles; Hai Pham; Michael Lovelock; Ellen Yorke; Guang Li; Laura Happersett; Andreas Rimner; Gig Mageras
Journal:  Med Phys       Date:  2018-11-13       Impact factor: 4.071

5.  Simultaneous MV-kV imaging for intrafractional motion management during volumetric-modulated arc therapy delivery.

Authors:  Margie A Hunt; Mark Sonnick; Hai Pham; Rajesh Regmi; Jian-ping Xiong; Daniel Morf; Gig S Mageras; Michael Zelefsky; Pengpeng Zhang
Journal:  J Appl Clin Med Phys       Date:  2016-03-08       Impact factor: 2.102

6.  Retrospective analysis of MV-kV imaging-based fiducial tracking in prostate SBRT treatment.

Authors:  Kevin Crotteau; Wei Lu; Sean Berry; Laura Happersett; Sarah Burleson; Weixing Cai
Journal:  J Appl Clin Med Phys       Date:  2022-03-26       Impact factor: 2.243

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.